Stay updated on Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial
Sign up to get notified when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.

Latest updates to the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page
- Check5 days agoChange DetectedThe page revision is updated to v3.5.2; the previous revision v3.5.0 has been removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page shows a new revision version, updating from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check62 days agoChange DetectedNo significant content changes detected; observed differences are minor UI/layout adjustments that do not affect the information presented for the trial. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision: v3.4.2 is now displayed, and the older government funding/operating-status notices were removed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check77 days agoChange DetectedAdded a government-funding notice informing users about potential delays and the NIH Clinical Center's status, with guidance to check cc.nih.gov and opm.gov for current operations. Updated the site revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.3%

Stay in the know with updates to Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.